Isoniazid is used either alone or in combination with other drugs for the treatment of tuberculosis. It is also used for the prevention of tuberculosis. Chronic treatment of Isoniazid may cause severe liver damage leading to acute liver failure. The mechanism through which Isoniazid causes liver damage is investigated. Isoniazid treatment generates reactive oxygen species and induces apoptosis in Hep3B cells. It induces antioxidative and apoptotic genes leading to increase in mRNA expression and protein levels in Hep3B cells. Whole genome expression analysis of Hep3B cells treated with Isoniazid has resulted in differential expression of various genes playing prime role in regulation of apoptotic, antioxidative, DNA damage, cell signaling, cell proliferation and differentiation pathways. Isoniazid increased cytosolic Nrf2 protein level while decreased nuclear Nrf2 protein level. It also decreased ERK1 phosphorylation and treatment of Hep3B cells with ERK inhibitor followed by Isoniazid resulting in increased apoptosis in these cells. Two dimensional gel electrophoresis results have also shown differential expression of various protein species including heat shock proteins, proteins playing important role in oxidative stress, DNA damage, apoptosis, cell proliferation and differentiation. Results suggest that Isoniazid induces apoptosis through oxidative stress and also prevents Nrf2 translocation into the nucleus by reducing ERK1 phosphorylation thus preventing cytoprotective effect.
Introduction
Isoniazid is one of the cheapest and most effective drugs used for the treatment of tuberculosis since 1950. Isoniazid is metabolized in liver by various metabolizing enzymes such as N-acetyl transferase which acetylates it into N-acetylisoniazid. N-acetylisoniazid is then biotransformed into isonicotinic acid and monoacetylhydrazine. Monoacetylhydrazine is N-hydroxylated by the cytochrome P450 mixed oxidase system and causes hepatotoxicity via formation of a reactive intermediate metabolite. Antituberculosis drug-induced hepatotoxicity (ATDH) is a serious concern in tuberculosis treatment and management of hepatotoxicity. However, the mechanism of toxicity of ATDH is not yet known completely and further understanding of the mechanisms associated with ATDH is greatly required to facilitate a rational approach in the treatment.
In this study the role of Nrf2 (Nuclear factor, erythoid 2-like 2) is being investigated. Nrf2 induction occurs in the cell during oxidative stress which is caused by various environmental factors and chemicals including drugs [1] [2] [3] . These external stimuli induce generation of reactive oxygen species which in turn trigger Nrf2 activation and its translocation into the nucleus [4] . After its translocation into the nucleus, it binds to antioxidative response elements (ARE) sequences of various antioxidative and cytoprotective genes and then induces their transcription [5] [6] [7] . Protein products formed from these transcribed antioxidative and cytoprotective genes decrease reactive oxygen species and reduce the cell damages caused by them. Several reports have suggested a protective action for Nrf2-ARE signaling pathway against CYP2E1-dependent hepatic oxidative injury [8, 9] indicating Nrf2-ARE pathway may exhibit a protective effect on INH and RFP-induced hepatotoxicity.
Extracellular signal regulated kinase 1 (ERK1) in the cytosol acts in signaling cascade and phosphorylate Nrf2 and induces its translocation into the nucleus [10] . ERK1 regulates various cellular processes like cell proliferation, cell differentiation and cell cycle progression in response to various extracellular signals [11, 12] . In this study we hypothesized that Isoniazid inhibits Nrf2 phosphorylation by reducing ERK1 phosphorylation and interferes its translocation into the nucleus.
Results

Cell viability assay and IC 50 determination
Hep3B cells were treated with 20, 40, 60, 80, 100, 120 and 140 mM Isoniazid concentrations while controls were treated with DMEM medium. Cell viability observed was 94.73% at 20 mM INH while at 140 mM of INH cell viability was 35.53% with controls having 100% cell viability. At 80 mM of INH 50% cell viability was observed. Therefore, IC 50 for Hep3B cells for INH was calculated as 80 mM [ Fig. 1 ].
Reactive oxygen species estimation
Isonaizid induced reactive oxygen species (ROS) generation in Hep3B cells in a dose dependent fashion. ROS generation was increased with increase in Isoniazid concentration in comparison to controls, where 0.36% cells generated ROS. When Hep3B cells were treated with 5, 10 and 20 mM INH, ROS was generated by 10.35%, 27.65% and 38.50% of the cells respectively [ Fig. 2(A) ].
Apoptosis induction
In control Hep3B cell population, 0.36% of cells were in apoptosis while in cells treated with 5, 10 and 20 mM INH, percentage of cells undergoing apoptosis was found to be at 1.42, 23.34 and 48.35 respectively [ Fig. 2(B) ]. The result showed that Isoniazid induces apoptosis in Hep3B cells in a dose dependent manner.
2.4.
Messenger RNA level of apoptotic and antioxidative genes mRNA levels of apoptotic (Cyt C, Caspase 9) and antioxidative genes (Keap1, Nrf2) were observed to be significantly increased in a dose dependent fashion in Hep3B cells treated with different Isoniazid concentrations as compared to controls [ Fig. 3(A) ].
Caspase activity assay
Activities of Caspase 9 and Caspase 3 were increased in Hep3B cells treated with 10 and 20 mM of Isoniazid respectively [ Fig. 3  (B) ]. When caspase inhibitors were added to cell suspension before adding caspase substrate the activities of both Caspase 9 and Caspase 3 were observed to decrease in Hep3B cells.
Differential gene expression study
Following 20 mM INH treatment in Hep3B cells, whole genome mRNA expression was assessed by microarray analysis. A high statistically stringent criterion (p o0.05 and 2.2 fold change) for up-regulated genes filtered 39 genes (Table 2 ) while a high statistically stringent criterion (p o0.05 and 2.5 fold change) for down-regulated genes filtered 64 genes (Table 3) . Few differentially expressed transcript cluster Ids have shown no sequence similarity with any known genes and have not been assigned any biological function yet.
Affected pathways
Differentially expressed genes were clustered by IPA (Ingunity Pathway Analysis, Qiagen) software in which genes were classified based upon functional category and pathways. Genes belonging to same mechanisms were joined together to form a single pathway. Major pathways that showed signs of Isoniazid induced perturbations included development function, cellular movement, posttranslational modifications, energy production, cell to cell signaling, cell death, survival, cell growth and proliferation pathways [Figs. 4 and 5].
Validation of microarray results by quantitative real time PCR analysis
Differential expression of four up-regulated genes (Bak1, SH3KBP1, GADD45B and SNAI2) and four down-regulated genes (NDRG1, PIM1, UCP2 and THBS3) as observed in microarray analysis were further validated by quantitative real time PCR analysis [ Fig. 6 (A) and (B)]. The up regulated genes Bak1, SH3KBP1, GADD45B and SNAI2 were observed to be up-regulated by 6.91, 4.87, 5.13 and 4.39 folds respectively, following 20 mM INH treatment to Hp3B cells. Similarly the down-regulated genes NDRG1, PIM1, UCP2 and THBS3 were down regulated by 3.87, 4.56, 6.34 and 5.02 fold respectively, following 20 mM INH treatment to Hep3B cells.
Expression of apoptotic genes at protein level
Isoniazid induced oxidative stress in Hep3B cells was confirmed by Cyt C release from mitochondrial inner membrane. Cytochrome C released from mitochondrial inner membrane was observed by Western blot analysis and this increase was proportional to Isoniazid concentrations. Cyt C binds apoptotic protease activating factor 1 (Apaf 1) which in turn binds to Procaspase 9 and converts it into Caspase 9. Caspase 9 protein level in Isoniazid treated Hep3B cells, was also observed to increase in a dose dependent fashion. Protein amount of both Cyt C and Caspase 9 was increased, from 5 mM to 10 and 20 mM of INH in comparison to control Hep3B cells [ Fig. 7(A) ]. Keap1 protein was also observed to increase in Hep3B cells treated with Isoniazid and this increase in Keap1 protein was also proportional to Isoniazid concentrations [ Fig. 7(A) ]. Densitometric results of bands of Cytochrome C, Caspase 9 and Keap1 are shown in Fig. S1 .
Cytosolic and nuclear Nrf2 protein level
Cytosolic Nrf2 protein level was observed to be increased in Hep3B cells treated with Isoniazid while the nuclear Nrf2 protein was observed to decrease [ Fig. 7(B) ]. This change in cytosolic and nuclear Nrf2 protein levels was proportional to Isoniazid concentrations. Protein amount of cytosolic Nrf2 was increased, from 5 mM to 10 and 20 mM of INH, as compared to control Hep3B cells while protein amount of nuclear Nrf2 was decreased, from 5 mM to 10 and 20 mM of Isoniazid, as compared to control Hep3B 
Phosphorylation of ERK1 into Phospho-ERK1
Phosphorylation of extra-cellular regulated kinase 1 (ERK1) protein into phospho-ERK1 was found to be decreased in the cytosol of Hep3B cells following Isoniazid treatment as compared to control Hep3B cells [ Fig. 7(C) ]. Phosphorylation of ERK1 in Hep3B cells was decreased when we increased INH concentrations from 5 mM to 10 and 20 mM. Densitometric results of bands of ERK1 and phospho-ERK1 are shown in Fig. S3. 
ERK1 inhibitor and apoptosis
When Hep3B cells were treated with ERK inhibitor, it induced apoptosis. 50 mM of ERK inhibitor induced apoptosis in 5.32% of Hep3B cells [ Fig. 8 
Two dimensional gel electrophoresis
After analyzing two dimensional gels, 30 protein spots, which were differentially regulated, were selected and cut [ Fig. 9 ]. These spots were either up-regulated by 41.5 times or down-regulated by o0.65 times. We observed that out of 30, 15 proteins were upregulated and 15 proteins were down-regulated (Table 4) . These proteins were identified by MALDI TOF/TOF analysis. These differentially expressed proteins were found to have role in oxidative stress, apoptosis, cell proliferation, t-RNA export, protein synthesis, development and cytoskeleton formation.
Discussion
Drug induced liver injury during the treatment of tuberculosis infection, is a major challenge to modern hepatology [15, 16] . Therefore, the assessment and monitoring of the hepatotoxicity of anti-tuberculosis drugs for prevention of liver injury are great concerns during disease treatment. The exact mechanism of antituberculosis drugs induced hepatotoxicity is not clearly understood yet. Some authors point to oxidative stress in hepatocytes by anti-tuberculosis drugs [17, 18] . Isoniazid is the most effective agent against tuberculosis and is used both for the treatment and the prophylaxis of this disease [19] . Toxic metabolites may also play an important role in the development of anti-TB drug induced hepatotoxicity (ATDH) [20] .
During oxidative stress, ROS is generated and it attacks the mitochondrial membrane resulting in Cyt C release. This released Cyt C binds to Apoptotic protease activating factor 1 (Apaf-1) which in turn binds to pro-caspase-9 to form apoptosome. The apoptosome cleaves pro-caspase-9 to its active form caspase-9, which in turn activates the effector caspase-3 [21] .
In Hep3B cells, twenty-four hours after treatment of 20 mM Isoniazid led to significant increase in number of annexin V FITC positive cells demonstrating apoptotis. ROS generation and apoptosis were found to be directly proportional to Isoniazid concentrations in Hep3B cells in this study. Apoptosis can be induced through two distinct pathways; one involves the ligation of the TNF/Fas-receptor with its ligand and followed by caspase-8 activation, leading to either direct activation of caspase-3, or through merger with the mitochondrial pathway via cleavage of the Bcl-2 family member, Bid. The other pathway is the mitochondria mediated caspase-9 activation pathway. Both pathways converge in caspase-3, culminating to cell death. Subsequent accumulation of cytochrome c in the cytosol has been shown to be responsible for activation of downstream proteolytic caspase and DNA fragmenting enzymes responsible for apoptotic cell death, and subsequent release of cytochrome c to peripheral circulation [22, 23] .
In the present study, it was observed that relative mRNA expressions of apoptotic genes (Cyt C and Caspase 9) as well as antioxidative genes (Keap1 and Nrf2) were increased in Hep3B cells following INH treatment. Further it was confirmed by activity assay of Caspase 9 and its down stream effector Caspase 3 that apoptosis in Hep3B cells is occurring through intrinsic pathway and not through extrinsic pathway following INH treatment. In Hep3B cells, administration of 10 and 20 mM of INH induced activation of caspase 9 and caspase 3 and it increased from 10 to 20 mM of INH. When cell suspensions of Hep3B cells incubated with 20 mM of INH for twenty-four hours were treated with caspase inhibitor following administration of caspase substrate, activities of both caspases were observed to be decreased.
Further, whole genome expression analysis was performed in Hep3B cells treated with 20 mM of Isoniazid to identify differentially expressed genes and their involvement in different pathways by microarray study. High throughput expression profiling made it possible for identification of various genes whose expression has changed following INH treatment. Their differential expression indicates hindrance of various roles in diverse pathways. Hep3B cells treated with Isoniazid resulted in differential regulation of 103 genes of which 39 were up-regulated and 64 were downregulated. Most of the genes were engaged in apoptosis, oxidative stress, cell proliferation, post-translational modification, cell signaling, cellular movement and developmental disorder. In addition, validation of few important differentially expressed genes in microarray findings using quantitative real time PCR [24] substantiates these results. As a result, identification of genes with similar expression changes, at such a high stringency indicates important biological functions under these circumstances. 
Several genes were found up regulated. For example following five genes: C12orf5, GLS, GADD45B, DDIT4 and GLUL were involved in oxidative stress and DNA damage. Genes like BAK1, SH3KBP1, SNAI2, TNFRSF12A and MAGED1 were involved in programmed cell death and DHFR, CTGF, ASS1, ID1, NDRG1, PIM1, ARHGAP19, PFKL, THBS3 and ACCN2 were found to play role in the cell proliferation. Similarly seven genes i.e. UIMC1, BMP2, IRS4, NOG, EXOC4, IFITM1 and NRN1 were found to be engaged in cell signaling pathways. One of the identified genes was Chromosome 12 open reading frame 5 (C12orf5) that increases NADPH production to help limit reactive oxygen species (ROS) and lowers cell death [25] . In BCL2-antagonist/killer 1 (BAK1), SH3-domain kinase binding protein 1 (SH3KBP1), Snail homolog 2 (SNAI2), Tumor necrosis factor receptor superfamily (TNFRSF12A), member 12A and Melanoma antigen family D 1 (MAGED1) genes BAK1, SH3KBP1, SNAI2 and TNFRSF12A were up-regulated while MAGED1 was down-regulated following Isoniazid treatment. BAK is a fundamental outer mitochondrial membrane protein and a key cell death initiator [26] . It further confirms that INH induced apoptosis through intrinsic pathway. ERK1. As a result, possibly due to the inhibition of Nrf2 translocation, Nrf2 may not be able to bind ARE sequences of the antioxidative and cytoprotective genes and activate them. In 2D gel electrophoresis results of Hep3B cells treated with INH, we have selected only those protein spots which were either upregulated by 41.5 fold or down-regulated by o0.65 fold. It was observed that total 30 proteins were differentially expressed under the criteria selected by us. Out of these 30 differentially expressed proteins, 15 proteins were detected to be up-regulated whereas 15 proteins were detected to be down-regulated. Thirteen differentially expressed proteins were found to be engaged in oxidative stress and DNA damage response. These proteins were Chaperonin Hsp60, Stress induced phosphoprotein1, 60 kDa Heat shock protein, Creatine kinase B, Cofilin, Inorganic pyrophoaphatase, Chain A Horf6A Novel Human Peroxidase enzyme, Alpha globin, Beta globin, Rho protein GDP dissociation inhibitor, Endoplasmin precursor, Transformation upregulated nuclear protein and Chain A Tapasin Erp57. Creatine kinase B (CKB), a cytosolic isoform of creatine kinase, demonstrates up-regulated expression in a variety of cancers. CKB knockdown reduced glucose consumption and lactate production, and raised ROS production and oxygen consumption. This recommended that CKB knockdown reduced cytosolic glycolysis and resulted in a tumor suppressive metabolic state in Skov3 cells [29] . Cofilin1 (CFL-1) over-expression enhances radiosensitivity and is associated with reduced DNA repair capacity [30] .
Five differentially expressed proteins observed from the 2D results in Hep3B cells treated with INH had role in apoptosis pathway. These proteins were BiP protein, Peroxiredoxin 4, Nucleophosmin/B23, EF1A1 and Eukaryotin translation initiator. The endoplasmic reticulum is the place where folding occurs for newly synthesized proteins that are destined for the cell surface. Additionally, it is the primary cellular storage site for calcium. Calcium homeostasis is needed for proper polypeptide folding and secretion of selective proteins as well as for intracellular signaling events that occur inside the cell. BiP/GRP78 is a lumenal stress protein of the endoplasmic reticulum (ER) that interacts with polypeptide folding intermediates transiting the secretory compartment [31] . Enzymes CK2, PKC, PLK1, CDKs, and PKA could phosphorylate B23 at higher number of sites. B23 phosphorylation is associated to cellular processes such as cell survival, apoptosis, cell proliferation, and reply to DNA damage stimulus [32] . eEF1A1 expression has clear effects on the proliferation enhancement and apoptosis inhibition of Jurkat cells, which may be intervened by the up-regulation of PI3K/Akt/NF-κB and PI3K/Akt/ mTOR signaling pathway [33] .
Six differentially expressed proteins observed were found to have role in Cell proliferation and differentiation. These were Cyclophilin, Heterogenous nuclear ribonucleoprotein A2, Heterogenous nuclear ribonucleoprotein F, Heterogenous nuclear ribonucleoprotein H, Non-POU containing octamer binding protein and POTE Ankyrin domain family member E. CypB induced by hypoxia stimulates the survival of HCC via a positive feedback loop with HIF-1α, demonstrating that CypB is a novel candidate target for developing chemotherapeutic agents against HCC and colon cancer [34] . Three differentially expressed proteins (KRT73 protein, Alpha tubulin and Beta actin like protein) were found to have role in maintaining cytoskeleton of the cell while three differentially expressed proteins (Enolase, ATP synthase subunit beta and Triose phosphate isomerase) were seen to play role in ATP synthesis pathway and maintaining energy reservoir of the cell. 
Conclusions
Isoniazid generated reactive oxygen species and induced apoptosis in Hep3B cells by increasing mRNA and protein level of various genes playing important roles in apoptosis, oxidative stress, cell signaling, cell proliferation and differentiation pathways. It also decreased the phosphorylation of ERK1 as a result of which it might not able to activate Nrf2 and its translocation into the nucleus and could not activate ARE to protect the Hep3B cells undergoing apoptosis following Isoniazid treatment.
Materials and method
Chemicals and biochemicals
All the chemicals were purchased from Sigma Aldrich. DMEM (Invitrogen), Whole genome expression kit (Ambion), cDNA synthesis kit (Applied Biosystem), SYBR Green (Roche), Annexin V FITC kit (Calbiochem), IPG strip, IPG buffer (GE Healthcare), Primary antibodies Caspase 9, Cyt C, Nrf2, ERK1, Phospho-ERK1, β-actin, Lamin B (all from Santacruz Biotechnology, USA), Keap1 (Thermo Scientific, USA) and Secondary antibodies (Santacruz Biotechnology, USA) were purchased. ERK1 inhibitor was purchased from Calbiochem.
Cell culture
Hep3B cells were obtained from our institutional cell repository. These cells were maintained at sub-confluence in 95% air and 5% CO 2 in a humidified atmosphere at 37°C. DMEM (Dulbecco's modified eagles medium) was used for cell cultivation. Cells were supplemented with 10% FBS, penicillin (100 units/ml) (both from GIBCO, Invitrogen). Hep3B cells were sub-cultured by discarding culture media and subsequently washing them with PBS, then adding Trypsin-EDTA (0.25% Trypsin and 0.53 mM EDTA) and incubating the cells for 2-5 min at 37°C in CO 2 incubator. Now cells were aspirated by gentle pipetting. Fresh growth media was added to it and appropriate aliquots of cell suspension were added to new culture vessel.
Cell viability assay
In order to calculate 50% growth inhibitory concentration (IC 50 ) of Isoniazid, Hep3B cells were seeded and grown for 24 h. Now, cells were treated with different concentrations of Isoniazid. 24 h later media was removed and cells were incubated in MTT for 4 h. Then MTT was removed and DMSO was added to each well and cells were incubated for 45 min in dark. Then OD was taken at 570 nm on Elisa Reader (BIO-TEK).
Estimation of reactive oxygen species generation (ROS)
Intracellular ROS generated in Hep3B cells following INH treatment were analyzed using the fluorescent probe 2',7'-dichlorofluorescin diacetate(DCFDA), a non-fluorescent compound under normal condition, which is converted into highly fluorescent dichlorofluorescein (DCF) by ROS. Hep3B cells were seeded in T25 flask and grown for next 24 h. After 24 h, these cells were washed with 1 Â PBS pH 7.4 and treated with different concentrations of INH for 24 h. Then, after 24 h cells were scraped in the media. Now cells were taken in 15 ml centrifuge tube and centrifuged at 1200 RPM for 5 min at 4°C. Supernatant was removed and cells were washed with 1 Â PBS pH 7.4. These cells were then re-suspended in 500 mL of PBS. Subsequently, 10 mL of 1 mM DCFDA was added to these cells for reactive oxygen species (ROS) estimation. Samples were incubated for 20-30 min at 37°C and fluorescence was monitored on a fluorescence activated cell sorting (FACS) flow cytometer (Beckman Coulter, USA) with excitation wavelength at 488 nm and emission wavelength at 530 nm [13] . 
cDNA synthesis and qRT-PCR analysis
Hep3B cells were seeded and treated with 5, 20 and 40 mM of Isoniazid. Total RNA was isolated with Trizol (Invitrogen) manually. 5 mg of total RNA was used for cDNA synthesis which was performed using cDNA synthesis kit (High Capacity cDNA Reverse Transcription Kit, Applied Biosystems, USA) according to manufacturer's protocol. Program for cDNA synthesis was incubation steps at 25°C for 10 min, 37°C for 120 min, 85°C 5 min and 4°C forever. Expression of CytC, Caspase 9, Nrf2, Keap1 and PKCδ genes was examined using qRT-PCR on LightCycler480 PCR system (Roche Diagnostics, Germany). The reaction mixture contained 50 ng of analyzed cDNA. The amplification of each sample was performed in triplicate in three independent experiments using a Light Cycler 480 SYBR Green I master (Roche Diagnostics, Germany) after which Cp values were averaged. For each primer pair, a melting curve analysis was performed according to instrument. The program in brief was an initial incubation of 50°C for 2 min hold (UDG incubation) and 95°C for 10 min followed by 40 cycles at 95°C for 15 s, 58°C for 30 s and final extension at 72°C for 20 s. Differential expression was calculated by 2 À ΔΔCT method. β-actin was used as internal control and used to normalize ratios between samples [14] . Primer sequences for this study are given in Table 1 .
Caspase activity assay
Hep3B cells were seeded and grown for 24 h. After that cells were treated with 10 and 20 mM of Isoniazid for next 24 h. Then Caspase 9 and Caspase 3 activity were measured using Caspase 3 and Caspase 9 activity assay kit (Calbiochem, USA) according to manufacturer's protocol. Caspase activities were measured by detection with a fluorescence spectrophotometer (Varian, Cary Eclipse) and the fluorescence was measured at an excitation/ emission wavelength of 400/505 nm.
Whole gene expression studies
Whole genome expression studies were performed by Microarray analysis. Total RNA from untreated and INH treated (20 mM) Hep3B cells was isolated manually by TriZol (Invitrogen). RNA quality and quantity were checked by formaldehyde gel electrophoresis and spectrophotometer respectively. RNA samples with approximately 2:1 ratio of 28 S: 18 S rRNA and 260/280 values Z1.8 were used for gene expression analysis. First strand was synthesized from total RNA and then second strand was synthesized. Then cRNA was synthesized by in vitro transcription and purified. Further sense strand cDNA was synthesized from cRNA and purified. Now cDNA was fragmented, labeled and loaded on Human Gene 1.0 ST Array Chip and sealed with white tough tag. For hybridization, Chip was transferred to the Hybridization Chamber (Affymetrix Gene Chip Hybridization Oven 645) and incubated for 16 h at 45°C with 60 rpm speed. After hybridization, Human Gene 1.0 ST Array Chip was washed in wash chamber (Affymetrix Gene Chip Fluidisc Station 450) to remove the unbounded fragmented cDNA. After washing, array was scanned (Affymetrix Gene Chip Scanner) and Microarray Data was analyzed by Gene Spring software and pathway analysis was performed by Ingunity Pathway Analysis (IPA) software from Qiagen. Eight differentially regulated genes were validated by quantitative real time PCR.
Western blot analysis
Cytosolic and nuclear proteins were isolated from Hep3B cells and liver tissue by ProteoJET cytosolic and nuclear protein extraction kit (Fermentas); according to manufacturer's protocol proteins were quantified using Bradford reagent. 50 mg protein from each sample was separated on 15% SDS-PAGE and transferred on to a nitrocellulose membrane using a semi-dry electroblotting apparatus (GE Healthcare, UK). Transfer was examined by Ponceau S stain and washed with TDW until the stain disappeared. Membrane was blocked overnight in 5% Non-Fat dried milk at 4°C. Blocking membrane was washed with 0.1% PBST and probed with 1°antibodies. After 1°antibody incubation, further washing was done in 0.1% PBST. Membrane was incubated in HRP conjugated 2°a ntibody and washed again. Enhanced chemi-luminescent detection reagent was used to develop the blots. Blots were further used for densitometric analysis (Image J) and normalization. Experiments were carried out in triplicates and values were averaged.
2D gel electrophoresis
Hep3B cells were incubated with INH for 24 h. Now whole cell lysates were prepared (7 M Urea, 2 M Thiourea ) and total protein concentration was estimated by Bradford assay. Six gels (three control and three treatment gels) were run independently in a pH range of 3-10 (13 cm long IPG strip). IEF was performed with 400 mg of protein samples on immobilized pH gradient IPG strips (GE Healthcare) in IEF machine. Proteins were separated in the second dimension by 12% SDS-PAGE, and protein spots were visualized by coomassie brilliant blue (CBB) staining. All the gels were scanned with an Image scanner (GE Healthcare) and quantitatively analyzed using Image Master 2D Platinum 7.0 software (GE Healthcare). For each protein spot, from both control and treatment gels, fold volume change of each spot was calculated by dividing % volume of treatment spot with control spot. We have selected the spots whose fold volume change was 41.5 were upregulated, whereas o0.65 were down-regulated. Gel to gel and staining techniques variations were overcome by comparing each protein spot to a number of other protein spots in the same gel whose expression did not change under given experimental conditions.
Protein identification by MALDI-TOF
The differentially appearing protein spots were carefully excised with a cut pipette tip, collected in eppendorf tubes, and destained by washing in 50 mM ammonium bicarbonate-ACN solution followed by two alternative washing steps with 50% ACN and 50 mM ammonium bicarbonate (ABC). The gel pieces were dehydrated at room temperature with 100% ACN and covered with 10 ml of trypsin (working solution: ng/mL prepared from 100 ng/mL stock solution in 50 mM ammonium bicarbonate) overnight at 37°C. The spots were grinded and the peptides were extracted in 10 mL of 70% ACN. The eluate was dried and stored at À 80°C. The peptides were resuspended in 5 ml of 20% acetonitrile (ACN) and 0.1% trifluoro acetic acid (TFA) and sonicated for 3 min before processing for MS. Thirty measurements were performed using MALDI-TOF/TOF tandem mass spectrometer (AB4800) and protein pilot software (Applied Biosystems, Foster City, CA, USA). After acquisition of spectra, peptide masses for each protein spot were analyzed by 4000 Series Explorer Software Version 3.5.3 (AB SCIEX) and a peak list of mono-isotopic masses was generated prior to MS/MS data search. The tandem mass spectra were stored in a combined Mascot Generic Format (MGF) file using "Peak to Mascot" tool, searched against NCBI-nr database (June 2014) through Mascot search engine version 2.4.01 (http://www.ma trixscience.com). Search was performed on the following parameters; taxonomy, all; single missed cleavage; precursor mass tolerance 20 ppm; fragment ion tolerance 0.05 Da; carbamido methylation of cysteines as fixed and oxidation of methionine as variable modification. Decoy parameter was checked to minimize the false discovery rate. $70% protein spots were identified.
Statistical analysis
GraphPad Prism 5 was used for analyzing mice serum parameters and quantitative real time PCR data. Image J was used for densitometric calculation of Western blotting bands. All the experiments were performed in triplicate independently. ANOVA method was used for analyzing 2D gel spots. All experiments were performed in triplicate independently and each image is representative of one of those images.
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